APA (7th ed.) Citation

Hsieh, J. C., Chiang, P., Hung, T., Chao, Y., Kuo, Y., Wen, C., . . . Wang, H. (2021). Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence. Wiley.

Chicago Style (17th ed.) Citation

Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.

MLA (8th ed.) Citation

Hsieh, Jason Chia‐Hsun, et al. Definitive Concurrent Chemoradiotherapy with Paclitaxel Plus Carboplatin Is Superior to Cisplatin Plus 5‐fluorouracil in Patients with Inoperable Esophageal Squamous Cell Carcinoma Using Retrospective, Real‐world Evidence. Wiley, 2021.